A ten-gene risk score model (C17orf97, GALNT10, RPP30, KIFC1, HCFC2, BC043172, TSPAN13, DNAJB9, FBN1, and EIF4G2) and a four-lncRNA prognostic risk model (RP4-803 J11.2, RP1-43E13.2, RP11-553 L6.5, and ZFY-AS1) were established to predict the OS of MM patients (Zhou et al., 2015; Hu et al., 2016). This evidence concerns the gene FBN1 and Miyoshi myopathy.